Showing 3531-3540 of 5062 results for "".
Urticaria: Dr. Hawkes
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/urticaria-dr-hawkes/32690/Jason Hawkes, MD, talks about how to manage and approach chronic spontaneous urticaria patients, as well as novel therapeutic options, all of which he covered in "Urticaria Update 2025" at Maui Derm 2025.Eczematous Dermatitis: Dr. Zirwas
https://practicaldermatology.com/programs/practical-dermatology/eczematous-dermatitis-dr-zirwas/32689/Matthew Zirwas, MD, talks about the therapeutic strategies for non-atopic dermatitis—particularly hand dermatitis and facial dermatitis—that he covered during "Eczematous Dermatitis Update 2025: Contact, Hand, Head and Neck, Eyelid and More" at Maui Derm 2025.Liquid Rhinoplasty and Beyond: Injectable Pearls
https://practicaldermatology.com/videos/scientifically-speaking/liquid-rhinoplasty-and-beyond-injectable-pearls/20008/From the best approach to safe and effective liquid nose corrections to tips for enhancing outcomes and streamline operations, Michael Somenek, MD; Kay Durairaj, MD; Shino Bay Aguilera, DO; and Corey Hartman, MD share their best tips with host Joel L. Cohen, MD.Sensus Healthcare: What's Next
https://practicaldermatology.com/topics/skin-cancer-photoprotection/sensus-healthcare-whats-next/19947/Along with other healthcare companies, Sensus faced challenges in 2020 as the COVID-19 pandemic emerged. But CEO Joe Sardano says the company is poised for success in 2021 and beyond. He discusses efforts to optimize physician reimbursement and strategies to expand access for patients.Sensus Healthcare: What's New
https://practicaldermatology.com/topics/skin-cancer-photoprotection/sensus-healthcare-whats-new/19946/Adding to its flagship SRT-100 device for superficial radiation therapy, Sensus has launched the Sculptura® Radiotherapy Oncology System and is poised to bring new aesthetic devices to market. Sensus CEO Joe Sardano says that as it grows, the company remains focused on relationships with its clientsRF Technologies: What should you know?
https://practicaldermatology.com/videos/scientifically-speaking/rf-technologies-what-should-you-know/19848/With so many radiofrequency devices now on the market and new ones in development, aesthetic specialists need to know how to select the proper tool for each patient need. E. Victor Ross, MD and Erez Dayan, MD join host Joel L. Cohen, MD to go beyond the marketing jargon to assess the science and cliDeveloping PsA: Risk Factors for Psoriasis Patients
https://practicaldermatology.com/topics/psoriasis/developing-psa-risk-factors-for-psoriasis-patients/19651/Can patients with psoriasis lessen their chance of developing psoriatic arthritis? Ronald Prussick, MD discusses the known risk factors and the importance of weight and a low BMI for these patients. He also talks about non-alcoholic fatty liver syndrome in this patient population.M22™ with ResurFX™ - A User's Perspective
https://practicaldermatology.com/topics/general-topics/m22-with-resurfx-a-user-s-perspective/18803/Dr. Palm shares her perspective on the M22 IPL system with non-ablative one-pass resurfacing, and why it is one of the most popular procedures in her clinic.Restylane Lyft Approved, Analyzing New Quality of Life Data
https://practicaldermatology.com/videos/dermwire-tv/dermwire-restylane-lyft-approved-analyzing-new-quality-of-life-data--ibalorid/18878/Restylane Lyft from Galderma approved for mid face volume enhancement, New data analyzes significance of patient quality of life in diseases like psoriasis and atopic dermatitis, Merz North America establishes new headquarters in Raleigh, NC, and Boston unveils free sunscreen dispensers.Get Your Future in Focus with NewDermMD
https://practicaldermatology.com/topics/practice-management/get-your-future-in-focus-with-newdermmd/21209/